In this study, we examined DLG5 expression in paired of TAM‐sensitive and resistant breast cancer tissues and employed TAM‐sensitive and resistant ER+ breast cancer cells to determine the effect of altered DLG5 expression on TAM sensitivity, apoptosis and stemness as well as TAZ expression. This evidence concerns the gene ESR1 and breast cancer.